71MO Clinical and Biomarker Analyses of Intratumoral CD40 Agonist Sotigalimab in Combination with Pembrolizumab in Metastatic Melanoma: A Phase I/II Trial
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2024)